Skip to content

Effectiveness of Running Therapy on Depression.

Randomised controlled trial into the effectiveness of running therapy in adults patients with depression.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20278
Enrollment
220
Registered
2009-07-02
Start date
2009-07-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Besides usual care, patients in the intervention group will be enrolled in a six months supervised, group physical activity program (running therapy or Nordic walking). In total 40 sessions (twice a w

Sponsors

Symfora groep
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18-65; 2. Diagnoses of unipolar depression, or bipolar depression, or seasonal depression not responding to light therapy (10 sessions of 1 hour) (using DSM-IV criteria); 3. Baseline Hamilton Rating Scale of Depression (HRSD) score of 14 or higher; 4. (Will be) treated for depression.

Exclusion criteria

Exclusion criteria: 1. Patients with comorbid disorders (including depression due to another comorbid condition, psychotic disorder, schizophrenia, schizoaffective disorder or obsessive compulsive disorder, anxiety disorder as primary diagnosis); 2. Patients in longstay facilities (including day care) or with complex pathology, treatment resistant depression and multiple hospital admissions with little effect on the depressive state; 3. Significant cardiovascular disease or other medical conditions which contra-indicates exercise therapy; 4. Contraindications for walking and/or running; 5. Pregnancy; 6. Addiction to alcohol and other drugs as a primary diagnosis (DSM-IV criteria Substance Depence); 7. High suicide risk; 8. Regular physical exercise (2-3 times a week on a high-intensity).

Design outcomes

Primary

MeasureTime frame
Depression symptoms (the Hamilton Rating Scale for Depression). Timepoints: 6 and 12 months.

Secondary

MeasureTime frame
1. Metabolic syndrome: length/weight2 (BMI), waist circumference, systolic and diastolic blood pressure, fasting glucose, triglycerides, total cholesterol, HDL-cholesterol, cholesterol/HDL-ratio, creatinine and Cockroft clearance. Timepoint: 6 and 12 months; 2. Quality of Life (WHO-DAS) at 6 and 12 months; 3. Cost effectiveness (TIC-P, Euroqol, subjective health, VAS) at 6 and 12 months.

Contacts

Public ContactFrank Kruisdijk

Postbus 3015

FR.Kruisdijk@symfora.nl+31 (0)33-4609803

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)